BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28970574)

  • 1. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene.
    Cheon CK; Lim SH; Kim YM; Kim D; Lee NY; Yoon TS; Kim NS; Kim E; Lee JR
    Sci Rep; 2017 Oct; 7(1):12527. PubMed ID: 28970574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis.
    Citterio A; Arnoldi A; Panzeri E; Merlini L; D'Angelo MG; Musumeci O; Toscano A; Bondi A; Martinuzzi A; Bresolin N; Bassi MT
    J Neurol; 2015 Dec; 262(12):2684-90. PubMed ID: 26410750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF1A-related autosomal dominant spastic paraplegias (SPG30) in Russian families.
    Rudenskaya GE; Kadnikova VA; Ryzhkova OP; Bessonova LA; Dadali EL; Guseva DS; Markova TV; Khmelkova DN; Polyakov AV
    BMC Neurol; 2020 Aug; 20(1):290. PubMed ID: 32746806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia.
    Pennings M; Schouten MI; van Gaalen J; Meijer RPP; de Bot ST; Kriek M; Saris CGJ; van den Berg LH; van Es MA; Zuidgeest DMH; Elting MW; van de Kamp JM; van Spaendonck-Zwarts KY; Die-Smulders C; Brilstra EH; Verschuuren CC; de Vries BBA; Bruijn J; Sofou K; Duijkers FA; Jaeger B; Schieving JH; van de Warrenburg BP; Kamsteeg EJ
    Eur J Hum Genet; 2020 Jan; 28(1):40-49. PubMed ID: 31488895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia.
    Ylikallio E; Kim D; Isohanni P; Auranen M; Kim E; Lönnqvist T; Tyynismaa H
    Eur J Hum Genet; 2015 Oct; 23(10):1427-30. PubMed ID: 25585697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up until early adulthood in autosomal dominant, complex SPG30 with a novel KIF1A variant: a case report.
    Spagnoli C; Rizzi S; Salerno GG; Frattini D; Fusco C
    Ital J Pediatr; 2019 Dec; 45(1):155. PubMed ID: 31796088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
    Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
    J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary spastic paraplegia caused by compound heterozygous mutations outside the motor domain of the KIF1A gene.
    Krenn M; Zulehner G; Hotzy C; Rath J; Stogmann E; Wagner M; Haack TB; Strom TM; Zimprich A; Zimprich F
    Eur J Neurol; 2017 May; 24(5):741-747. PubMed ID: 28332297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating KIF1A mutations in a Taiwanese cohort with hereditary spastic paraplegia.
    Hsu SL; Liao YC; Lin KP; Lin PY; Yu KW; Tsai YS; Guo YC; Lee YC
    Parkinsonism Relat Disord; 2022 Oct; 103():144-149. PubMed ID: 36155026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an in-frame homozygous KIF1A variant causing a mild SPG30 phenotype in a Korean family.
    Lee B; Song HH; Kim YR; Kim JH; Cho ST; Lee JH; Kim UK; Park JS
    Gene; 2023 Jun; 870():147403. PubMed ID: 37001573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations.
    Klebe S; Lossos A; Azzedine H; Mundwiller E; Sheffer R; Gaussen M; Marelli C; Nawara M; Carpentier W; Meyer V; Rastetter A; Martin E; Bouteiller D; Orlando L; Gyapay G; El-Hachimi KH; Zimmerman B; Gamliel M; Misk A; Lerer I; Brice A; Durr A; Stevanin G
    Eur J Hum Genet; 2012 Jun; 20(6):645-9. PubMed ID: 22258533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation.
    Xiaojing W; Yanyan M; Ruonan D; Xiaolin L; Haiyan Z; Jian M; Yi L; Wenjie S; Qiji L
    Stem Cell Res; 2020 Mar; 43():101727. PubMed ID: 32045731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration.
    Stevanin G; Azzedine H; Denora P; Boukhris A; Tazir M; Lossos A; Rosa AL; Lerer I; Hamri A; Alegria P; Loureiro J; Tada M; Hannequin D; Anheim M; Goizet C; Gonzalez-Martinez V; Le Ber I; Forlani S; Iwabuchi K; Meiner V; Uyanik G; Erichsen AK; Feki I; Pasquier F; Belarbi S; Cruz VT; Depienne C; Truchetto J; Garrigues G; Tallaksen C; Tranchant C; Nishizawa M; Vale J; Coutinho P; Santorelli FM; Mhiri C; Brice A; Durr A;
    Brain; 2008 Mar; 131(Pt 3):772-84. PubMed ID: 18079167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-associated mutations hyperactivate KIF1A motility and anterograde axonal transport of synaptic vesicle precursors.
    Chiba K; Takahashi H; Chen M; Obinata H; Arai S; Hashimoto K; Oda T; McKenney RJ; Niwa S
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18429-18434. PubMed ID: 31455732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia.
    Zhao M; Chen YJ; Wang MW; Lin XH; Dong EL; Chen WJ; Wang N; Lin X
    Mol Diagn Ther; 2019 Dec; 23(6):781-789. PubMed ID: 31630374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on clinical and molecular genetics of hereditary spastic paraplegia 11 patients in China.
    DU J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1729-1732. PubMed ID: 36748384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy.
    Lee JR; Srour M; Kim D; Hamdan FF; Lim SH; Brunel-Guitton C; Décarie JC; Rossignol E; Mitchell GA; Schreiber A; Moran R; Van Haren K; Richardson R; Nicolai J; Oberndorff KM; Wagner JD; Boycott KM; Rahikkala E; Junna N; Tyynismaa H; Cuppen I; Verbeek NE; Stumpel CT; Willemsen MA; de Munnik SA; Rouleau GA; Kim E; Kamsteeg EJ; Kleefstra T; Michaud JL
    Hum Mutat; 2015 Jan; 36(1):69-78. PubMed ID: 25265257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel
    Yoshikawa K; Kuwahara M; Saigoh K; Ishiura H; Yamagishi Y; Hamano Y; Samukawa M; Suzuki H; Hirano M; Mitsui Y; Tsuji S; Kusunoki S
    eNeurologicalSci; 2019 Mar; 14():34-37. PubMed ID: 30582020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of autosomal dominant, pure form spastic paraplegia with thinning of the corpus callosum].
    Tomiyasu H; Hayashi R; Watanabe R; Honda M; Yoshii F
    Rinsho Shinkeigaku; 1998 May; 38(5):435-9. PubMed ID: 9805990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2.
    Crimella C; Baschirotto C; Arnoldi A; Tonelli A; Tenderini E; Airoldi G; Martinuzzi A; Trabacca A; Losito L; Scarlato M; Benedetti S; Scarpini E; Spinicci G; Bresolin N; Bassi MT
    Clin Genet; 2012 Aug; 82(2):157-64. PubMed ID: 21623771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.